Pages
'Chained CPI' hurts seniors
Robert Reich Apr 10, 2013
Obama's proposal to recalculate the rate of inflation hurts seniors who spend more on health care than the rest of us.
New technology lets deaf, hard of hearing make calls in HD
Ben Johnson Apr 10, 2013
A company called Purple Communications has new technology to help people who are deaf or hearing impaired communicate digitally through an American Sign Language (ASL) interpreter.
Ray Kurzweil on the surprising simplicity of the human brain
David Brancaccio Apr 5, 2013
Legendary inventor and futurist Ray Kurzweil shares his thoughts on the way humans and technology are becoming more intertwined and an irony of the human mind.
Dementia is highest cost disease and rising
Dan Gorenstein Apr 4, 2013
A report in the latest issue of the New England Journal of Medicine says the U.S. spends more on treating dementia than any other disease including cancer and heart disease.
As the cellphone turns 40, the story behind the famous first call
David Brancaccio Apr 4, 2013
40 years ago the cellphone was invented by Martin Cooper at Motorola, much to the dismay of a competing team at AT&T's Bell Labs.
Bitcoin continues to spike in the wake of Cyprus
Jeremy Hobson Apr 3, 2013
Whenever there's a big economic crisis, investors usually flock to the safety of gold or U.S. government bonds. But when things got crazy in the last couple weeks in Cyprus, it was something called Bitcoin that surged in value.
Inbox overload: How to time your emails for less stress
Janell Burley Hofmann Apr 3, 2013
When it comes to your email, how soon are you expected to reply? And when is it ok to delay?
Nursing exams keep pace with health care tech advances
Kate Casey Apr 2, 2013
It helps to be up on the latest tech if you want to be a registered nurse. This week the National Council of State Boards of Nursing is rolling out a new update to its nurse licensing exam.
India Novartis patent ruling: Good for access, bad for innovation?
Dan Gorenstein Apr 1, 2013
India's Supreme Court has rejected a patent filed by Swiss drug maker Novartis for its cancer drug. The decision has implications for the pharmaceutical industry and millions of people in poor countries.
India rejects Novartis cancer drug patent
Rahul Tandon Apr 1, 2013
The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.
